We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for vorasidenib citrate (Servier Laboratories (Aust) Pty Ltd)
Active ingredients
vorasidenib citrate
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Immediate release, film coated tablet
Indication
Treatment of IDH-mutant diffuse glioma
Therapeutic area
Oncology